Picture of Biohit Oyj logo

BIOBV — Biohit Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareAdventurousMicro CapContrarian

Brief: Biohit Publishes Results From Comparison Study With ColonView-FIT

Jan 18 (Reuters) - Biohit Oyj  BIOBV.HE :
    * BIOHIT NEW-GENERATION FECAL IMMUNOCHEMICAL TEST
(COLONVIEW-FIT)
IS  SUPERIOR TO TRADITIONAL GUAIAC TEST IN COLORECTAL CANCER
SCREENING
    * COLONVIEW-FIT SHOWED A SENSITIVITY FAR SUPERIOR TO
COMPARISON
TEST IN DETECTING FOB IN PATIENTS REFERRED FOR COLONOSCOPY

Source text for Eikon:  ID:nGNEc77nqm 
Further company coverage:  BIOBV.HE 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Biohit Oyj

See all news